Form 4 for PDSB PDS Biotechnology Corp
Accepted 2022-12-02 00:00:00 ET · period of report 2022-12-02 · accession 0001140361-22-044259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-02 | 2022-12-02 | PDSB | BEDU-ADDO FRANK | Pres, CEO, Dir | F - Tax | $9.78 | -175.2K | 690.9K | -20% | -$1.71M |
| D | 2022-12-02 | 2022-12-02 | PDSB | BEDU-ADDO FRANK | Pres, CEO, Dir | M - OptEx | $6.57 | +219.5K | 866.0K | +34% | +$1.44M |
| D | 2022-12-02 | 2022-12-02 | PDSB | BEDU-ADDO FRANK | Pres, CEO, Dir | M - OptEx | $0.00 | -219.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | F | D | 175,184 | $9.78 | 690,866 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-02 | M | A | 219,535 | $6.57 | 866,050 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-12-02 | M | D | 219,535 | $0.00 | 0 | D | $6.57 · — to 2022-12-03 | 219,535 Common Stock | (F1) This stock option was fully vested in accordance with its terms. |